Guest guest Posted December 16, 2011 Report Share Posted December 16, 2011 Opportunity for those of us who have complaints also.Notice section about comments section on Facebook.Can anyone put together a powerpoint to go on YouTube about the dangers of Miralax?I will provide 'clips' if someone can make several short vignettes to counter those put out by the manufacturers/pushers of their most dangerous drug!'From FDA mailing list promo:Subject: Social Media Without Enforcement Risks No question about it: social media presents a host of problems for drug and device companies. Still, for brands that manage their presence successfully, the upside potential is huge. But what's the secret to keeping control over your brand as people share on social media? What does an FDA-proof social media presence look like? What happens if consumers use YouTube, Twitter or Facebook to report previously unknown adverse events? How do you present balanced promotions and important safety information using social media? Here's how to develop a social media strategy that keeps you compliant and competitive. New from FDAnews Social Media Strategies for Drug and Device Companies Order Today No matter how fast the rules continue to change, this new FDAnews report will help drug- and devicemakers tap the power of social media. In it, you'll find real-world strategies for building a strong presence on Facebook, Twitter and YouTube — without giving up control over your brand or risking marketing and advertising enforcement. With little specific guidance from the FDA, this report fills a critical gap, connecting you with the social media strategies working most effectively for today's drug- and devicemakers. Buy now to build a social media strategy that keeps you compliant and competitive, despite the challenges: How the FDA is applying its regulations to social media marketing and advertising — and tips for avoiding problems How to address Facebook's new comment policy — before random comments damage your brand and trigger FDA enforcement actions Dos and don'ts for keeping messaging balanced and in compliance Best practices from today's safest and most successful social media campaigns How to handle adverse events reported via social media How to trouble shoot other risks and challenges most effectively Today's market realities demand that you tap the power of social media marketing and communications. Rely on this report to take the guesswork out of success. Order your copy today. Buy Now Social Media Strategies for Drug and Device Companies is offered by FDAnews in print or PDF format for $377. Act now: place your order here. (Add $10 shipping and handling for printed reports shipped to the U.S. and Canada, or $35 per report shipped elsewhere. Virginia residents, please add 5 percent sales tax.) Satisfaction Guaranteed Your purchase is 100% guaranteed. If for any reason you decide the report is not for you, simply return the undamaged hard copy within 30 days of purchase and you'll receive a full refund (less shipping/handling). For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase to receive a refund. Four Easy Ways to Order Please mention priority code 11D16 when ordering. Order online. Call toll free (inside the U.S.) or +1 . Use your American Express, Visa or MasterCard. Fax your purchase order to +1 . Mail your check to: FDAnews, 300 N. Washington St., Suite 200 Falls Church, VA 22046-3431. FDAnews, 300 N. Washington St., Suite 200, Falls Church, VA 22046-3431 This is a promotional message. If you are having trouble viewing this message, click here. Copyright © 2011 by FDAnews Click here to unsubscribe. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.